Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

20
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
20
Dementia l: Introduction01:22

Dementia l: Introduction

31
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
31

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative multidimensional psychosocial profiles of major depressive disorder patients with higher versus lower anhedonia burden: a cross-sectional study.

BMC psychiatry·2026
Same author

Predicting intraoperative blood loss using cervical vertebral bone quality scores in cervical corpectomy and fusion procedure.

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·2026
Same author

Brake-Drive Osteo System: Sequential Modulation of the Inflammatory Microenvironment and Osteogenesis for Osteoporotic Bone Defect Regeneration.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

Preoperative geriatric nutritional risk index is a reliable tool for predicting postoperative adjacent segment disease among elderly patients with degenerative lumbar diseases: a case control study.

BMC musculoskeletal disorders·2026
Same author

Assessment of Bone Mineral Density in Patients With Degenerative Spinal Disease by MRI-based Vertebral Bone Quality Score at Different Lumbar Vertebral Levels: An Observational Prospective Study.

Spine·2026
Same author

Organic-inorganic heterostructure empowers infected wound healing.

Journal of materials chemistry. B·2025

Related Experiment Video

Updated: Apr 28, 2026

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
09:33

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases

Published on: July 28, 2013

28.4K

Tensor Completion for Alzheimer's Disease Prediction From Diffusion Tensor Imaging.

Yixin Gou, Yipeng Liu, Fei He

    IEEE Transactions on Bio-Medical Engineering
    |February 13, 2024
    PubMed
    Summary
    This summary is machine-generated.

    This study introduces a novel tensor completion method to predict Alzheimer's disease progression using cognitive scores. The approach effectively captures score structures, outperforming existing methods for better disease diagnosis.

    More Related Videos

    Measuring Connectivity in the Primary Visual Pathway in Human Albinism Using Diffusion Tensor Imaging and Tractography
    13:26

    Measuring Connectivity in the Primary Visual Pathway in Human Albinism Using Diffusion Tensor Imaging and Tractography

    Published on: August 11, 2016

    12.3K
    Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
    09:47

    Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

    Published on: December 15, 2023

    1.0K

    Related Experiment Videos

    Last Updated: Apr 28, 2026

    Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
    09:33

    Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases

    Published on: July 28, 2013

    28.4K
    Measuring Connectivity in the Primary Visual Pathway in Human Albinism Using Diffusion Tensor Imaging and Tractography
    13:26

    Measuring Connectivity in the Primary Visual Pathway in Human Albinism Using Diffusion Tensor Imaging and Tractography

    Published on: August 11, 2016

    12.3K
    Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
    09:47

    Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

    Published on: December 15, 2023

    1.0K

    Area of Science:

    • Neuroscience
    • Medical Imaging Analysis
    • Machine Learning

    Background:

    • Alzheimer's disease (AD) is a progressive neurodegenerative disorder.
    • Accurate prediction of AD progression is crucial for patient management.
    • Existing methods often overlook the structural information within cognitive scores.

    Purpose of the Study:

    • To propose a novel method for predicting Alzheimer's disease progression.
    • To leverage the inherent structure of cognitive scores for improved prediction.
    • To address limitations in current prediction models.

    Main Methods:

    • Developed a relation-aware tensor completion multitask learning (RATC-MTL) method.
    • Represented cognitive scores as a third-order tensor to preserve global structure.
    • Integrated tensor completion with linear regression to model score correlations and biological features.

    Main Results:

    • The proposed RATC-MTL method achieved superior performance in predicting cognitive scores compared to single-task and state-of-the-art multi-task algorithms.
    • The method demonstrated the best overall performance in classifying Alzheimer's disease progression.
    • Results confirmed the framework's effectiveness in utilizing global cognitive score structure.

    Conclusions:

    • The developed framework effectively explores global structure information in cognitive scores.
    • Tensor completion offers a novel approach for disease diagnosis, particularly in data-scarce scenarios.
    • This method enhances the prediction of Alzheimer's disease progression.